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Bcl-2 family proteinLeukotriene B4, an arachidonic acid-derived lipid mediator, is a known proinﬂammatory agent that has a di-
rect effect upon neutrophil physiology, inducing reactive oxygen species generation by the NADPH oxidase
complex and impairing neutrophil spontaneous apoptosis, which in turn may corroborate to the onset of
chronic inﬂammation. Despite those facts, a direct link between inhibition of neutrophil spontaneous apopto-
sis and NADPH oxidase activation by leukotriene B4 has not been addressed so far. In this study, we aim to
elucidate the putative role of NADPH oxidase-derived reactive oxygen species in leukotriene B4-induced
anti-apoptotic effect. Our results indicate that NADPH oxidase-derived reactive oxygen species are critical
to leukotriene B4 pro-survival effect on neutrophils. This effect also relies on redox modulation of nuclear fac-
tor kappaB signaling pathway. We have also observed that LTB4-induced Bad degradation and mitochondrial
stability require NADPH oxidase activity. All together, our results strongly suggest that LTB4-induced
anti-apoptotic effect in neutrophils occurs in a reactive oxygen species-dependent manner. We do believe
that a better knowledge of the molecular mechanisms underlying neutrophil spontaneous apoptosis may
contribute to the development of more successful strategies to control chronic inﬂammatory conditions
such as rheumatoid arthritis.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Neutrophils are considered the ﬁrst line of defense and they bear a
highly specialized killing machinery [1]. Among the several cytotoxic
mechanisms displayed by these terminally differentiated leukocytes,
the most aggressive ones are the release of pre-formed intracellular
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l rights reserved.oxygen and nitrogen species [2]. Among all the ROS-generating sys-
tems, the NADPH oxidase (NADPHox) is the most specialized one,
being absolutely essential to an appropriate host defense [3,4].
This multi-enzymatic complex, which is constituted by membrane
and cytosolic subunits, can be activated by both particulated and sol-
uble stimuli which are able to induce the translocation of the cytosolic
subunits to the membrane-bound ones [5–7]. Once assembled, this
complex can transfer electrons from cytosolic NADPH to the molecu-
lar oxygen present in the extracellular or phagosomal environment,
generating superoxide (O2•−) and, subsequently, O2•−–derived spe-
cies [3,8].
A growing body of evidence has suggested that beside theirmicrobi-
cidal and toxic properties, ROS can also act as signal transductionmedi-
ators in several biological systems [8]. However, ROS apparently exhibit
a dual role in cell physiology,which implies that the amount of ROS pro-
duced is a critical parameter for the cell outcome [9]. High concentra-
tions of ROS generally induce cell death either by necrosis or
apoptosis [10–13]. The latter is particularly observed in a specialized
type of cell death, known as phagocytosis-induced cell death (PICD),
in whichNADPHox-derived ROS contributes to neutrophil death during
phagocytosis of opsonized pathogens [14]. Conversely, subtoxic levels
of ROSmay account for the activation of pro-survival pathways, leading
to inhibition of neutrophil spontaneous apoptosis [15–18].
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redox status, inducing paradoxical ROS-mediated effects. It is well
established that proinﬂammatory agents not only can prolong neutro-
phil responsiveness but also can extend its lifespan through regulation
of anti-apoptotic routes, therefore delaying neutrophil spontaneous ap-
optosis [19,20]. This phenomenon is highly desirable during the onset of
an acute inﬂammatory response, as these cells will remain exerting
their defense functions for a greater period of time. On the other
hand, excessively prolonged neutrophil survival can threaten tissue ho-
meostasis due to the release of highly histotoxic products, including
ROS [21,22]. This inappropriate extension of neutrophil lifespan is ac-
companied by impaired clearance of apoptotic bodies and consequent
inhibition of resolution of inﬂammation [23,24].
Leukotriene B4 (LTB4), a lipid mediator derived from arachidonic
acid via 5-lipoxygenase pathway, is produced primarily by inﬂamma-
tory cells, being considered a potent neutrophil activator [25,26].
Among its effects, LTB4 promotes changes in calcium inﬂux, cell polar-
ization, chemotaxis and degranulation, as well as generation of
NADPHox-derived ROS [27–29]. In many cell types, LTB4 can also pro-
mote nuclear factor kappaB (NF-κB) activation. NF-κB is a redox-
sensitive transcription factor usually conﬁned to the cytoplasm of
resting cells, as these molecules are associated to chaperones called
inhibitor of κB (IκB). However, a number of stimuli trigger the activa-
tion of IκB kinases (IKK), which phosphorylate IκB, leading to the re-
lease of NF-κB (which in turn translocate to the nucleus) and signals
IκB degradation by the proteasome 26S [30].
NF-κB induces the transcription of various proinﬂammatory mole-
cules such as cytokines, growth factors, and adhesion molecules
[31,32]. NF-κB is often related to cell survival, since it controls genes
encoding pro-survival proteins, particularly anti-apoptotic members
of the Bcl-2 family such as Bcl-2, Bcl-xL, A1, and Mcl-1 [33]. Bcl-2 pro-
teins, which can also be proapoptotic (Bad, Bim, Bik, Bax, Bak among
others), are considered both “gatekeepers” and “gate crashers”, as
they controlmitochondrial outermembrane integrity and thereforemi-
tochondrial transmembrane potential (ΔΨm, an early apoptosis indica-
tor), a critical checkpoint of apoptosis [34].
It has been previously shown that LTB4 delays neutrophil sponta-
neous apoptosis [29,35]. Pétrin and collaborators [36] have reported
that LTB4-stimulation activates signaling pathways classically in-
volved in cell survival, such as PI3K and ERK, as well as enhanced
Mcl-1 expression. However, the correlation between LTB4-induced
delay of neutrophil apoptosis and the generation of ROS evoked by
this eicosanoid remained unknown.
This study aims to elucidate the putative role of NADPHox-derived
ROS in LTB4-induced anti-apoptotic effect. Adopting a pharmacologi-
cal approach, based in the use of two structurally and functionally
unrelated compounds, diphenyleneiodonium (DPI, a ﬂavoprotein in-
hibitor extensively used as NADPHox negative modulator) and
apocynin (an inhibitor of p47phox cytosolic subunit translocation),
we assessed NADPHox involvement in LTB4 anti-apoptotic effect on
human peripheral blood neutrophils and the putative role of redox-
dependent NF-κB activation on these effects. In order to clarify the un-
derlying molecular mechanisms controlling LTB4 anti-apoptotic effect,
the impact of NADPHox and NF-κB systems on the expression of the
proapoptotic protein Bad aswell as onΔΨm, of LTB4-stimulated neutro-
phils was also investigated.
2. Material and methods
2.1. Reagents
DPI, apocynin, pyrrolidine dithiocarbamate (PDTC), Trolox™, bovine
serum albumin (BSA), phenylmethylsulphonyl ﬂuoride (PMSF), phorbol
myristate acetate (PMA), DNAse, RNAse, polyethylenoglycol-superoxide
dismutase (peg-SOD), BAY 11-7082 and soybean trypsin inhibitor
(SBTI) were purchased from Sigma-Aldrich (St. Louis, MO, USA).Dulbecco's modiﬁed eagle's medium (DMEM) was acquired from
GIBCO-BRL (Carlsbad, CA, USA). Polyvinylidene diﬂuoride membrane
(PVDF) was obtained from Amersham (Piscataway, NJ, USA). Ficoll-
Paque™ was purchased from GE Healthcare. All antibodies utilized
were acquired from Santa Cruz Biotechnology (Santa Cruz, CA, USA). En-
hanced chemiluminescence system (ECL) was obtained from Pierce Bio-
technology (Rockford, IL, USA). JC-1 and annexin Vwere purchased from
Molecular Probes (Eugene, OR, USA). LTB4 originated fromBiomol (Plym-
outh Meeting, PA, USA) and was kindly donated by Dr. Peters-Golden
(University of Michigan Health System, Ann Arbor, MI, USA). 12-HHT
and LY 255283 were purchased from Cayman (Ann Arbor, MI, USA).
CP-105,696 was donated by Dr. H. Showell (Pﬁzer, Groton, CT, USA).
2.2. Human neutrophil isolation and culture
Neutrophils were isolated from EDTA (0.5%)-treated peripheral
venous blood of healthy donors by density gradient centrifugation
over Ficoll-Paque™ followed by dextran sedimentation as previously
described [37]. Residual erythrocytes were removed by hypotonic
lysis by addition of 0.2% sterile saline and solution concentration is
reconstituted to 0.9% after addition of equal volume 1.6% sterile sa-
line. Isolated neutrophils were incubated in DMEM supplemented
with 10% heat-inactivated fetal bovine serum (FBS), 100 U/mL of pen-
icillin and 100 mg/mL of streptomycin or Hank's balanced salt solu-
tion (HBSS), at 37 °C in a humidiﬁed atmosphere containing 5% CO2.
In all experimental conditions, more than 98% of the cells were viable,
according to trypan blue dye exclusion assay.
2.3. ROS production assays
2.3.1. Chemiluminescence assay
Neutrophils (6×105 cells/well, ﬁnal volume of 200 μL) were
resuspended inHBSS and placed in awhite 96well plate. Cells were load-
ed with lucigenin (250 μM) or luminol (500 μM) and pretreated or not
with apocynin (10 μM), DPI (10 μM) or polyethylenoglycol-superoxide
dismutase (peg-SOD, 200 U/mL) for 15 min at 37 °C in a 5% CO2 incuba-
tor. Cells were stimulated or not with LTB4 (30–300 nM) or PMA
(30 nM), a known NADPHox activator (positive control). Non-
stimulated cells were considered the control group. Chemilumines-
cence was measured in each well for 20 s throughout 60 min
(lucigenin assay) or 10 min (luminol assay) using a VICTOR3
1420 Multilabel Plate Reader (PerkinElmer, Waltham, MA, USA).
2.3.2. Cytochrome c reduction assay
Neutrophils (1×106) were suspended in HBSS containing cyto-
chrome c (500 μg/mL) and catalase (11 μg/mL). After apocynin
(10 μM) pretreatment for 15 min in the indicated groups, cells
were stimulated or not with LTB4 (30–300 nM) or PMA (30 nM)
in the presence or the absence of SOD (200 U/mL, internal control)
for 30 min at 37 °C and 5% CO2 atmosphere. Cells were centrifuged,
supernatants were collected and absorbance (λ=550 nm) was
measured in multilabel plate reader Envision 2104 (PerkinElmer,
Waltham, MA, USA). The molar coefﬁcient was calculated as:
ε550=21×103 M−1×cm−1.
2.4. Apoptosis detection
2.4.1. Annexin V-FITC binding
Annexin V is a serum protein that selectively interacts with
phosphatidylserine residues, which are exposed on the outer leaﬂet
of the plasma membrane when cells undergo apoptosis [16].
In order to estimate the content of annexin V-positive cells, fresh
neutrophils (control group) or neutrophils incubated or not with
LTB4 (30–300 nM) for 20 h at 37 °C in a 5% CO2 atmosphere were
washed with binding buffer (10 mM HEPES (pH=7.4), 150 mM
NaCl, 5 mM KCl, 1 mM MgCl2 and 1.8 mM CaCl2) and resuspended
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dilution). After a 20 min-incubation at room temperature in the dark,
400 μL of binding buffer was added and the samples were immediately
analyzed in a FACScalibur™ ﬂow cytometer (Becton–Dickinson).
2.4.2. Morphology
After pre-incubation or not with DPI (10 μM), apocynin, (10 μM),
PDTC (100 nM), BAY 11-7082 (10 μM), CP-105,696 (1 μM), peg-SOD
(200 U/mL), Trolox™ (50 μM) or LY 255283 (0.3 μM) for 15 min, neu-
trophils were stimulated with LTB4 (300 nM) or 12-HHT (15–300 nM)
for 20 h at 37 °C in a 5% CO2 incubator. Cells were cytocentrifuged,
stained with Diff-Quik™ and counted under an Olympus BX41 optical
microscopy (×1000) to determine the proportion of cells showing apo-
ptotic morphological features. Cells were considered apoptotic when
displaying pyknotic nuclei and cell volume shrinkage. At least 400
cells were counted per slide.
2.5. Cell extract preparation
For whole cell extracts, neutrophils (5×106 cells) were resuspended
in lysis buffer (50 mM HEPES, pH 6.4, 1 mM MgCl2, 10 mM EDTA, 1%
Triton X-100, 1 μg/mL DNase, 0.5 μg/mL RNase) containing the fol-
lowing protease inhibitors: 1 mM PMSF, 1 mM benzamidine, 1 μM
leupeptin, and 1 μM soybean trypsin inhibitor (Sigma-Aldrich).
Total protein content was determined by Bradford method [38].
For nuclear extracts, neutrophils (5×106 cells) were lysed in ice-
cold buffer A (10 mM HEPES, pH 7.9, 10 mM KCl, 0.1 mM EDTA,
0.1 mM EGTA, 1 mM DTT, and 0.5 mM PMSF), and after a 15-min in-
cubation in ice, Nonidet P-40 was added to a ﬁnal concentration of
0.5% (v/v). Nuclei were collected by centrifugation (1810×g; 5 min
at 4 °C). The nuclear pellet was suspended in ice-cold buffer C
(20 mM HEPES (pH=7.9), 400 mM NaCl, 1 mM EDTA, 1 mM EGTA,
1 mM DTT, 1 mM PMSF, 1 μg/mL pepstatin, 1 μg/mL leupeptin, and
20% (v/v) glycerol) and incubated for 30 min. Nuclear proteins were
collected in the supernatant after centrifugation (12,000×g; 10 min
at 4 °C).
2.6. Western Blot analysis
Whole cell as well as nuclear extracts were performed as previ-
ously described [22]. Brieﬂy, lysates were denatured in sample buffer
containing SDS and 2-mercaptoethanol and heated in boiling water
for 3 min. Whole cell extracts (30 μg of protein) or nuclear extracts
(25 μL) were submitted to a 12% or 15% SDS-PAGE and proteins
were transferred to PVDF membranes. Rainbow molecular weight
markers (Amersham Pharmacia Biotech) were run in parallel to esti-
mate molecular weights. Membranes were blocked with tween-PBS
containing 2% BSA for 30 min and incubated for approximately 15 h
with anti-Bad (1:500), anti-α-tubulin (1:1000), anti-IκB-α (1:500),
anti-phosphorylated IκB-α (1:500), anti-NF-κB p65 subunit (1:1000)
or anti-Histone H3 (1:1000). After three washes (10 min each) with
tween-PBS at room temperature, PVDF membranes were incubated
with anti-rabbit or anti-mouse IgG antibodies conjugated to biotin
(1:10,000) for 1 h and then incubated with streptavidin conjugated to
peroxidase (1:10,000, Caltag Laboratories, Burlingame, CA). Immunore-
active proteins were visualized by ECL system. Protein bands were
quantiﬁed by optical densitometry by Scion Image software (Scion
Co., MD). Results are expressed as the band densitometry mean±SEM
of at least three independent experiments.
2.7. Flow cytometry assessment ofmitochondrial transmembrane potential
Themitochondrial stability wasmeasured by the use of the cation-
ic dye JC-1, which incorporates to the mitochondrial intermembrane
space. The monomer (green) can polymerize forming clusters known
as J-aggregates (red) in a transmembrane potential-dependent manner[39]. Therefore, viable, non-apoptotic cells exhibit a pronounced red-
dish ﬂuorescence of mitochondria that can be detectable by ﬂow analy-
sis (in the FL-2 channel). Conversely, apoptotic process results in loss of
ΔΨm and a subsequent decrease of the reddish ﬂuorescence shifting to
an increase in green ﬂuoresce (as seen in FL-1 channel, [40]).
Isolated neutrophils (5×106/mL) were stimulated with LTB4
(0–300 nM) after being pretreated or not with apocynin (10 μM) or
PDTC (100 nM) for 15 min. Cells were incubated for 20 h at 37 °C in
a 5% CO2 atmosphere. JC-1 dye (10 μg/mL) was then added to each
group and after a 30-min incubation at 37 °C in 5% CO2 atmosphere,
labeled cell suspensions were submitted to FACScalibur analysis.
FL-1 (515–545 nm) and FL-2 (564–606 nm) channels were assessed.
Results expressed are mean±SEM of FL-2/FL-1 ratio.
2.8. Statistical analysis
Statistical signiﬁcance was evaluated by Analysis of Variance
(ANOVA) followed by Bonferroni comparison test.
3. Results
3.1. Role of NADPHox-derived ROS and NF-κB activation in LTB4-delayed
neutrophil apoptosis
The LTB4-dependent ROS generation by human neutrophils was
evaluated by two different chemiluminogenic probes, lucigenin (selec-
tive to extracellular O2•− generation) and luminol (broad-spectrum,
cell permeable probe). As shown in Fig. 1, LTB4 evoked a transient and
potent ROS generation, in a concentration dependent manner, peaking
in very early time points (≤1 min; Fig. 1A–B). In order to estimate the
ROS accumulation promoted by LTB4, area under curve was calculated,
revealing that only higher concentrations of LTB4 (100–300 nM) pro-
moted a signiﬁcant increase in ROS production when compared to
non-stimulated cells (Fig. 1C–D). The observed ROS generationwas sig-
niﬁcantly inhibited when cells were pretreated with the NADPHox in-
hibitors apocynin (10 μM) and DPI (10 μM), strongly suggesting that
these ROS are derived from NADPHox (Fig. 1E). Similar results were
also observed using the cytochrome c reduction assay, a classical ROS
generation measurement method (Fig. 1F).
It has been reported that LTB4 delays neutrophil spontaneous apo-
ptosis in vitro [29,35,36]. Coincidently, this effectwas observed in a con-
centration range in which this eicosanoid is able to promote ROS
generation. Accordingly, we observed that LTB4 was able to inhibit
neutrophil spontaneous apoptosis at the same concentration range
(Fig. 2A). Moreover, LTB4-induced inhibition of neutrophil spontaneous
apoptosis seems to require NADPHox activity, since LTB4 pro-survival
effect was abrogated by DPI (Fig. 2B–C) and apocynin (Fig. 2D). The
ROS scavenger Trolox™ and the cell-permeable antioxidant enzyme
peg-SOD (which dismutate superoxide anion) were also able to revert
LTB4-anti-apoptotic effect (Fig 2E). Conﬁrming LTB4 receptors' involve-
ment, pretreatment of neutrophils with BLT1 or BLT2 antagonists,
CP-105,696 and LY 255283 respectively, reverted LTB4 anti-apoptotic
effect (Fig. 2 F). Interestingly, NF-κB inhibition by PDTC and BAY
11-7082, also abrogated LTB4 anti-apoptotic effect (Fig. 2D).
3.2. LTB4-induced ROS generation impact on NF-κB activation
NF-κB is a transcription factor whose activation is triggered by a
number of proinﬂammatory agents, leading to cell activation, cyto-
kine synthesis and extension of neutrophil lifespan [33]. LTB4 pro-
moted NF-κB p65 subunit accumulation in nuclear extracts, a
parameter of activation of this signaling route. This effect was abro-
gated by NADPHox inhibition (Fig. 3A). LTB4 (300 nM) was also able
to strongly induce both IκB-α protein degradation and phosphoryla-
tion, critical steps to NF-κB activation. NADPHox-derived ROS also
plays an essential role in this event, since apocynin pretreatment
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Fig. 1. LTB4 induction of neutrophil ROS production. (A) Neutrophils (6×105 cells/well) were placed in a white ﬂat-bottom 96-well plate and stimulated or not with 30 nM (circles),
100 nM (squares) and 300 nM (triangles) of LTB4 in the presence of lucigenin. Data are expressed as percentage of increase when compared to the control group. (B) Same
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curve using lucigenin for 60 min (C), or luminol for 10 min (D, E). (F) Cells (1×106 cells/mL) were incubated with cytochrome c-supplemented medium in the absence or in
the presence of apocynin (10 μM) for 15 min, and stimulated or not with LTB4 (30–300 nM) after 30 min, cytochrome c reduction was assessed as detailed in the Material and
methods section. Results are mean±SEM of three to six independent experiments. The asterisks indicate a signiﬁcant difference when compared to the control (*, pb0.05; ***,
pb0.001). #, ## and ### indicate that the treatments signiﬁcantly reverted LTB4 effects (pb0.05, pb0.01 and pb0.001, respectively).
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(Fig. 3B–C), suggesting that LTB4-induced ROS lead to activation of
IKKs, resulting in IκB-α phosphorylation and consequent degradation,
and therefore NF-κB activation.3.3. LTB4-induced ROS production on the modulation of proapoptotic
members of Bcl-2 family and mitochondrial stability
The apoptotic process is critically regulated by Bcl-2 family pro-
teins, since the complex interaction between its members can cause
the preservation or the dissipation of ΔΨm, being the latter a phe-
nomenon closely related to the onset of apoptosis [41]. It had already
been described that LTB4 induces Mcl-1 accumulation in human neu-
trophils [36]. We observed that LTB4 (300 nM) rapidly induced degra-
dation of Bad, a Bcl-2 proapoptoticmember, in a NADPHox-derived ROS
dependent manner (Fig. 4).
LTB4 (100–300 nM) is able to maintain the FL-2/FL-1 ratio similar to
fresh, non-apoptotic neutrophils, thus preventing ΔΨm dissipation
(Fig. 5A). LTB4-induced ΔΨm maintenance relies on NADPHox-derivedROS signaling and NF-κB activation, once both apocynin and PDTC
abolished LTB4 protective effect (Fig. 5B).4. Discussion
Our data strongly indicate the importance of ROS signaling, par-
ticularly those derived from NADPHox complex, to the LTB4 anti-
apoptotic effect in human neutrophils in vitro. LTB4 is a potent
chemoattractant, exerting its effects at nanomolar concentrations,
eliciting adherence and aggregation of leukocytes to the blood ves-
sels [42,43]. Moreover, LTB4 stimulation also induces neutrophil de-
granulation, leading to increased release of lysosomal enzymes as
well as NADPHox enzymatic complex activation which causes subse-
quent ROS production. Interestingly, the LTB4 secretagogue effect is
exerted at higher concentrations when compared to those required
for neutrophil chemotaxis [27,44–46].
In our work, we have observed LTB4-induced ROS generation
using the chemiluminogenic probes lucigenin and luminol for its sen-
sitivity and accuracy. In addition, these assays allow continuous
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point assays. They also make it possible to discriminate which ROS
are being generated [47,48]. Lucigenin is mostly selective for O2•− re-
leased at the extracellular milieu while luminol detects a group of re-
active species derived from the myeloperoxidase (MPO)–hydrogen
peroxide (H2O2) system, which in turn, requires O2•− as substrate.
Among the reactive species detected by luminol are H2O2, hydroxyl
radical, hypochlorite and peroxynitrite [49].
Our results showed that LTB4 (300 nM) induced ROS production in
neutrophils in vitro, which depends on NADPHox activity, by both
chemiluminescence methods. Nevertheless, LTB4 (100 nM) ROS pro-
duction was detected in the luminol assay, an event also modulated
by apocynin pretreatment, whereas we did not detect ROS production
incited by this concentration using lucigenin assay. As luminol chemilu-
minescence depends onMPO involvement, it is possible that LTB4 stim-
ulation provokes mobilization of granular NADPHox followed by
plasma membrane NADPHox activation [50].
LTB4 inhibition of neutrophil apoptosis seems to require
NADPHox-derived ROS, since two different NADPHox inhibitors
prevented this prosurvival effect. DPI is a ﬂavoprotein inhibitorwidely used to prevent NADPHox activity [51,52], while apocynin
seems to have a more selective effect upon p47phox assembly and
consequent NADPHox activation [53,54]. Some recent works have
identiﬁed other effects related to apocynin treatment, including
non-speciﬁc NADPHox inhibition and oxidative stress induction,
but only in much higher concentrations [55–57].
We have also observed that peg-SOD and Trolox™ pretreatments
also abrogated the LTB4-induced anti-apoptotic effect. These data are
in agreement with the concept that ROS signaling mediated by
proinﬂammatory stimuli can trigger prosurvival pathways, supporting
ROS ambiguity in cell life/death balance [1,58].
LTB4 biological effects are exerted through two receptors: the
widely-studied high afﬁnity receptor BLT1 and the low afﬁnity recep-
tor BLT2. The high concentration range in which LTB4 induces ROS
generation has led to the proposition that this effect was modulated
by LTB4 binding to BLT2 [59,60]. However, our study suggests that
the two receptors are involved in LTB4 anti-apoptotic effect. BLT1
had been related to neutrophil survival [61] whereas BLT2 role in
cell survival was only observed in other cell types [62,63]. In fact,
we described that BLT2 activation by its agonist 12-HHT [64] can
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1995P. Barcellos-de-Souza et al. / Biochimica et Biophysica Acta 1823 (2012) 1990–1997delay neutrophil apoptosis, although in a less extensive manner than
LTB4 (Supplementary Fig. 1). Redundant roles for BLT receptors
[65,66] inclusive a possible heterodimerization mechanism [25], had
been already observed and further experiments are necessary to in-
vestigate this hypothesis.
NF-κB activation is also critically involved in LTB4-evoked pro-survival
signaling, as supported by our observations that pretreatment with both
PDTC and BAY 11-7082, a highly selective NF-κB inhibitor, prevented
LTB4 anti-apoptotic effect. It has been reported previously that lower
LTB4 (b30 nM)was only able to trigger amild NF-κB activation [31]. Fur-
thermore, it seems that the 100–300 nM concentration range is critical to
induce ROS-dependent p65 subunit translocation to the nucleus as well
as to induce a prompt redox-sensitive IκB-α phosphorylation and degra-
dation. We hope these results corroborate to strengthen ROS-mediated
modulation of NF-κB as a key mechanism involved in immunity and in-
ﬂammation [18,67,68].
Our data are in agreement with work by Pétrin and collaborators
[36], which shows that sub-micromolar concentrations of LTB4promote inhibition of neutrophil spontaneous apoptosis in a PI3K-
and MAPK-dependent manner, involving induction of Mcl-1 expres-
sion. Noteworthy, both pathways are redox-sensitive signaling routes
that converge to NF-κB activation, that corroborates to our hypothesis.
LTB4 stimulation alters the expression of Bcl-2 family proteins,
which are devoted to the control of apoptosis at the mitochondrial
level [36,69]. Resting neutrophils, as found in circulation under nor-
mal conditions, express low levels of anti-apoptotic Bcl-2 family pro-
teins, contrasting with extremely high expression of proapoptotic
ones. Proinﬂammatory/anti-apoptotic factors invert this scenario:
they promote a dramatic decrease in proapoptotic Bcl-2 proteins avail-
ability (both inducing proteolysis and heterodimerization with 14-3-3
proteins [70]), while inducing the expression of anti-apoptotic mem-
bers [71,72]. As expected, LTB4 promotes rapid Bad degradation in a
NADPHox activity-dependent fashion, which is in agreement with re-
ports describing modulation of Bcl-2 family expression by ROS [18,73].
This transient, but dramatic decrease in Bad cellular content may pre-
vent the insertion of proapoptotic Bcl-2 members (Bax, Bak) in the
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1996 P. Barcellos-de-Souza et al. / Biochimica et Biophysica Acta 1823 (2012) 1990–1997mitochondrial outer membrane, resulting in ΔΨm maintenance, thus
avoiding the release of proapoptotic factors conﬁned to the mito-
chondrial intermembrane space to the cytosol. We demonstrated in
this study that NADPHox-derived ROS are critical to ΔΨm preserva-
tion mediated by LTB4. NF-κB activity was also essential to LTB4-
induced mitochondrial stability, probably inducing expression of
anti-apoptotic Bcl-2 members, such as Mcl-1 [36].A
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when compared to the control (20 h) group.5. Conclusions
In summary, we demonstrate that LTB4, at concentrations found in
inﬂammatory sites, evokes NADPHox activation and subsequent ROS
production, leading to neutrophil survival. This effect relies on redox-
sensitive NF-κB activation as well as Bad degradation, maintaining mi-
tochondrial stability. As LTB4-induced anti-apoptotic effect is involved
in many inﬂammatory conditions, elucidating the molecular events re-
sponsible for its signaling could help to designmore rational and selective
therapies, particularly those that aim to control chronic inﬂammatory
disorders.
Supplementary data to this article can be found online at http://
dx.doi.org/10.1016/j.bbamcr.2012.07.012.Acknowledgements
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